Optimizing normal tissue sparing in ion therapy using calculated isoeffective dose for ion selection

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):756-62. doi: 10.1016/j.ijrobp.2011.08.006. Epub 2012 Mar 19.

Abstract

Purpose: To investigate how the selection of ion type affects the calculated isoeffective dose to the surrounding normal tissue as a function of both normal tissue and target tissue α/β ratios.

Methods and materials: A microdosimetric biologic dose model was incorporated into a Geant4 simulation of parallel opposed beams of protons, helium, lithium, beryllium, carbon, and neon ions. The beams were constructed to give a homogeneous isoeffective dose to a volume in the center of a water phantom for target tissues covering a range of cobalt equivalent α/β ratios of 1-20 Gy. Concomitant normal tissue isoeffective doses in the plateau of the ion beam were then compared for different ions across the range of normal tissue and target tissue radiosensitivities for a fixed isoeffective dose to the target tissue.

Results: The ion type yielding the optimal normal tissue sparing was highly dependent on the α/β ratio of both the normal and the target tissue. For carbon ions, the calculated isoeffective dose to normal tissue at a 5-cm depth varied by almost a factor of 5, depending on the α/β ratios of the normal and target tissue. This ranges from a factor of 2 less than the isoeffective dose of a similar proton treatment to a factor of 2 greater.

Conclusions: No single ion is optimal for all treatment scenarios. The heavier ions are superior in cases in which the α/β ratio of the target tissue is low and the α/β ratio of normal tissue is high, and protons are superior in the opposite circumstances. Lithium and beryllium appear to offer dose advantages similar to carbon, with a considerably lower normal tissue dose when the α/β ratio in the target tissue is high and the α/β ratio in the normal tissue is low.

MeSH terms

  • Beryllium / therapeutic use
  • Carbon / therapeutic use
  • Heavy Ion Radiotherapy
  • Helium / therapeutic use
  • Ions / therapeutic use*
  • Lithium / therapeutic use
  • Models, Biological*
  • Monte Carlo Method
  • Neon / therapeutic use
  • Organ Sparing Treatments / methods
  • Organ Sparing Treatments / standards*
  • Organs at Risk / radiation effects*
  • Phantoms, Imaging
  • Proton Therapy
  • Radiation Tolerance
  • Radiotherapy Dosage
  • Relative Biological Effectiveness

Substances

  • Ions
  • Helium
  • Neon
  • Carbon
  • Lithium
  • Beryllium